Pred-G

Product manufactured by Allergan, Inc.

Application Nr Approved Date Route Status External Links
NDA050586 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Pred-G ® Suspension Is Indicated For Steroid-Responsive Inflammatory Ocular Conditions For Which A Corticosteroid Is Indicated And Where Superficial Bacterial Ocular Infection Or A Risk Of Bacterial Ocular Infection Exists. Ocular Steroids Are Indicated In Inflammatory Conditions Of The Palpebral And Bulbar Conjunctiva, Cornea, And Anterior Segment Of The Globe Where The Inherent Risk Of Steroid Use In Certain Infective Conjunctivitides Is Accepted To Obtain A Diminution In Edema And Inflammation. They Are Also Indicated In Chronic Anterior Uveitis And Corneal Injury From Chemical, Radiation, Or Thermal Burns Or Penetration Of Foreign Bodies. The Use Of A Combination Drug With An Anti-Infective Component Is Indicated Where The Risk Of Superficial Ocular Infection Is High Or Where There Is An Expectation That Potentially Dangerous Numbers Of Bacteria Will Be Present In The Eye. The Particular Anti-Infective Drug In This Product Is Active Against The Following Common Bacterial Eye Pathogens: Staphylococcus Aureus, Streptococcus Pyogenes, Streptococcus Pneumoniae, Enterobacter Aerogenes, Escherichia Coli, Haemophilus Influenzae, Klebsiella Pneumoniae, Neisseria Gonorrhoeae, Pseudomonas Aeruginosa , And Serratia Marcescens .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments